Skip to main content
Thorax logoLink to Thorax
. 1963 Mar;18(1):10–15. doi: 10.1136/thx.18.1.10

Respiratory Function in Progressive Systemic Sclerosis

Mary Catterall 1,2, N R Rowell 1,2
PMCID: PMC1018732  PMID: 14019386

Full text

PDF
10

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAKEMORE W. S., FORSTER R. E., MORTON J. W., OGILVIE C. M. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957 Jan;36(1 Pt 1):1–17. doi: 10.1172/JCI103402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CADIGAN J. B., CUGELL D. W., GAENSLER E. A., MARKS A. Clinical determination of the diffusion capacity of the lungs; comparison of methods in normal subjects and patients with alveolar-capillary block syndrome. Am J Med. 1957 Jan;22(1):51–73. doi: 10.1016/0002-9343(57)90337-6. [DOI] [PubMed] [Google Scholar]
  3. FENNELL R. H., Jr, RODNAN G. P., VAZQUEZ J. J. Variability of tissue-localizing properties of serum from patients with different disease states. Lab Invest. 1962 Jan;2:24–31. [PubMed] [Google Scholar]
  4. MILLER R. D., FOWLER W. S., HELMHOLZ F. H., Jr Scleroderma of the lungs. Proc Staff Meet Mayo Clin. 1959 Feb 4;34(A):66–75. [PubMed] [Google Scholar]
  5. NICE C. M., Jr, MENON A. N., RIGLER L. G. Clinical and roentgenologic signs of collagen diseases involving the thorax. Dis Chest. 1959 Jun;35(6):634–650. doi: 10.1378/chest.35.6.634. [DOI] [PubMed] [Google Scholar]
  6. ROWELL N. R. Lupus erythematosus cells in systemic sclerosis. Ann Rheum Dis. 1962 Mar;21:70–75. doi: 10.1136/ard.21.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SALOMON A., APPEL B., DOUGHERTY E. F., HERSCHFUS J. A., SEGAL M. S. Scleroderma; pulmonary and skin studies before and after treatment with cortisone. AMA Arch Intern Med. 1955 Jan;95(1):103–111. doi: 10.1001/archinte.1955.00250070119014. [DOI] [PubMed] [Google Scholar]
  8. SPAIN D. M., THOMAS A. G. The pulmonary manifestations of scleroderma; an anatomic-physiological correlation. Ann Intern Med. 1950 Jan;32(1):152-61, illust. doi: 10.7326/0003-4819-32-1-152. [DOI] [PubMed] [Google Scholar]
  9. TRANQUADA R. E., SIMMONS D. H., MILLER J. H. Pulmonary fibrosis in scleroderma: report of a case with pulmonary function studies to evaluate corticosteroid and relaxin therapy. Arch Intern Med. 1960 Apr;105:607–612. [PubMed] [Google Scholar]
  10. WEST J. R., McCLEMENT J. H., CARROLL D., BLISS H. A., KUSCHNER M., RICHARDS D. W., Jr, COURNAND A. Effects of cortisone and ACTH in cases of chronic pulmonary disease with impairment of alveolar-capillary diffusion. Am J Med. 1951 Feb;10(2):156–165. doi: 10.1016/0002-9343(51)90238-0. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES